Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

PhRMA On The “Defensive”: Sen. Breaux Notes Criticism Is Bipartisan

Executive Summary

The brand name pharmaceutical industry must recognize that it is a convenient political target for members of Congress in both parties, Sen. John Breaux (D-La.) warned the Pharmaceutical Research & Manufacturers of America during the association's annual meeting April 3 in Palm Beach, Fla

You may also be interested in...



Rx “Tax Holiday” Nears President’s Desk Following House Passage

A tax change that would allow U.S. pharmaceutical companies to pay a far lower duty to "repatriate" up to $500 mil. claimed by overseas affiliates remains en route to becoming law, despite objections raised by the Bush Administration

Rx “Tax Holiday” Nears President’s Desk Following House Passage

A tax change that would allow U.S. pharmaceutical companies to pay a far lower duty to "repatriate" up to $500 mil. claimed by overseas affiliates remains en route to becoming law, despite objections raised by the Bush Administration

Congressional feedback on PhRMA annual meeting

Rep. Donna Christensen (D-V.I.) had a "very good discussion" with PhRMA at the group's recent annual meeting, she tells an Alliance of Minority Medical Associations conference in Washington, D.C. April 19. "It was a very frank and open discussion about the need to ensure that patients got the best medication for their particular illness or disease," Christensen said. "Despite often having differences of opinion, we consider the pharmaceutical industry our partners in providing health care." Christensen participated in a panel discussion on access to medicines at PhRMA (1"The Pink Sheet" April 12, 2004, p. 12)...

UsernamePublicRestriction

Register

PS043728

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel